|
|
|
|
 |
|
CardioDynamics Announces Strategic Alliance With Leading Medical Equipment Manufacturer in India |
| Companies mentioned in this article: |
|
CardioDynamics |
|
| 1/31/2008 @ 8:32 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
CardioDynamics (NASDAQ:CDIC) , the innovator and leader of Impedance Cardiography (ICG) technology, today announced a Strategic Alliance with Recorders and Medicare Systems, Ltd. (RMS), one of the largest manufacturers of medical equipment in India. Under the terms of the Distribution and Technology License Agreements, RMS will have rights to sell CardioDynamics manufactured BioZ ICG products in India and also will integrate BioZ ICG technology into RMS' patient monitoring products. CardioDynamics will receive product revenue for each ICG monitor and a licensing fee for each BioZ ICG kit purchased by RMS.
Michael K. Perry, Chief Executive Officer of CardioDynamics, stated, "We have made a concerted effort to diversify our business beyond the U.S. physician office market which is heavily dependent upon Medicare and private insurance reimbursement. These agreements with RMS are another step in driving our international growth initiatives and will build upon the recently announced record 50% year-over-year quarterly growth in our International business. Through our technology licensing strategies, we are increasing global access to our BioZ ICG technology and increasing the recurring revenue content of our business."
India, whose population exceeds one billion people, has significantly increased its healthcare expenditures over the past decade to more than $34 billion or roughly 6% of GDP. The population of individuals at least 60 years of age is projected to triple over the next 20 years to an estimated 190 million people.
Suman Jolly, Managing Director of RMS, stated, "We are proud to partner with the world's premier ICG monitoring company and to bring innovative medical technology to our healthcare system. The rebuilding of India's healthcare infrastructure, combined with the emergence of medical tourism and telemedicine, will drive strong demand for medical equipment. Additionally, the government is encouraging growth of the medical equipment market through policies such as a reduction in import duties on medical equipment, higher depreciation for life-saving medical equipment, and a number of other tax incentives."
India presently has one-fifth of the world average number of hospital beds per million population and an estimated 450,000 additional beds will be required by 2010 -- an investment estimated at over $25 billion.
Perry added, "We view this strategic alliance with RMS as beneficial on two major fronts. First, RMS has an extensive presence in the developing, healthcare market in India, which will be instrumental in helping to drive continued market adoption of our proprietary BioZ ICG technology. Secondly, we believe RMS will be an excellent technology partner to utilize for low cost development and manufacturing in the years ahead."
About CardioDynamics:
CardioDynamics (NASDAQ:CDIC) , the ICG Company, is the innovator and leader of breakthrough medical technology called Impedance Cardiography (ICG). The Company develops, manufactures and markets noninvasive diagnostic and monitoring technologies and electrodes. The Company's ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare and Philips Medical Systems. For additional information, please refer to the company's Web site at www.cdic.com/.
About Recorders and Medicare Systems:
Recorders and Medicare Systems, Ltd., located in Chandigarh, India was founded in 1979 and is engaged in the development, manufacturing, marketing and selling of electro-medical equipment to the Indian healthcare marketplace. The company has installed its products in nearly every major medical institution in India and has over 200 sales and service personnel based in 53 branch offices throughout the country. Additional information can be found on the company's website at www.rmsindia.com/. |
| BioTech / BioMedical / Medical |
|
|
| |
| Thursday, August 28, 2008 |
 |
|
Orexigen Therapeutics to Present at Upcoming Investor Conferences Posted 3:16 PM PST
Amylin Pharmaceuticals to Present at Thomas Weisel Healthcare, BioCentury NewsMakers, and Morgan Stanley Global Healthcare Conferences Posted 3:15 PM PST
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference Posted 3:14 PM PST
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference Posted 3:13 PM PST
Volcano Presentation at Thomas Weisel Conference to Be Webcast Posted 3:12 PM PST
Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008 Posted 3:12 PM PST
Illumina to Present at Upcoming Investment Conferences in September Posted 7:43 AM PST
Optimer Pharmaceuticals to Present at BioCentury NewsMakers Conference Posted 7:42 AM PST
ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on September 4, 2008 Posted 7:42 AM PST
|
| |
| Wednesday, August 27, 2008 |
|
|
Genoptix Announces Participation at the 2008 Southern California Investor Conference Posted 9:08 AM PST
|
| |
| Tuesday, August 26, 2008 |
|
|
Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA Posted 3:42 PM PST
Cyntellect to Collaborate With the Burnham Institute for Medical Research; In situ live cell manipulation on LEAP to empower purification of stem cells and their differentiated progeny Posted 8:57 AM PST
TorreyPines Therapeutics Receives NASDAQ Deficiency Notice Posted 8:50 AM PST
JMAR Technologies Awarded Development Contract by the Johns Hopkins University Applied Physics Laboratory Posted 8:29 AM PST
Aperio Receives FDA Clearance for ER and PR Image Analysis Applications Posted 7:52 AM PST
|
| |
| Monday, August 25, 2008 |
|
|
Amylin and Lilly Set Date and Time for Conference Call; Companies Will Discuss Recent FDA Advisory Regarding BYETTA Posted 4:17 PM PST
Cripps Translational Science Institute Contributes to Discovery of Predisposition Gene for Childhood Cancer Posted 4:13 PM PST
Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference Posted 4:12 PM PST
Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems Posted 6:15 AM PST
|
| |
| Friday, August 22, 2008 |
|
|
ALISO VIEJO--- Valeant Pharmaceuticals to Present at UBS Global Life Sciences Conference Posted 6:20 AM PST
|
| |
| Thursday, August 21, 2008 |
|
|
Moores UCSD Cancer Center Luau & Longboard Invitational Celebrates 15 Years of 'Surfing For A Cure' on August 24 Posted 4:14 PM PST
Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial Posted 4:13 PM PST
Patent Issued Related to Prometheus Proprietary Test Cbir1 Antigen Test Included in Diagnostic for Inflammatory Bowel Disease Posted 4:12 PM PST
Vaxfectin -formulated Measles DNA Vaccine Could Address Unmet Need for Infants Posted 4:11 PM PST
NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients Posted 4:03 PM PST
|
| |
| Tuesday, August 19, 2008 |
|
|
Karolinska Institute to Test Vical's Vaxfectin Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control Posted 7:59 AM PST
Invitrogen Launches Legionella Test to Streamline Surveillance Posted 7:29 AM PST
Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors Posted 7:26 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
